Literature DB >> 24566933

Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1β-induced chronic inflammation.

Wen Liang1, Jan H Lindeman2, Aswin L Menke3, Debby P Koonen4, Martine Morrison5, Louis M Havekes1, Anita M van den Hoek5, Robert Kleemann6.   

Abstract

The nature of the chronic inflammatory component that drives the development of non-alcoholic steatohepatitis (NASH) is unclear and possible inflammatory triggers have not been investigated systematically. We examined the effect of non-metabolic triggers (lipopolysaccharide (LPS), interleukin-1β (IL-1β), administered by slow-release minipumps) and metabolic dietary triggers (carbohydrate, cholesterol) of inflammation on the progression of bland liver steatosis (BS) to NASH. Transgenic APOE3*Leiden.huCETP (APOE3L.CETP) mice fed a high-fat diet (HFD) developed BS after 10 weeks. Then, inflammatory triggers were superimposed or not (control) for six more weeks. Mouse livers were analyzed with particular emphasis on hallmarks of inflammation which were defined in human liver biopsies with and without NASH. Livers of HFD-treated control mice remained steatotic and did not progress to NASH. All four inflammatory triggers activated hepatic nuclear factor-κB (NF-κB) significantly and comparably (≥5-fold). However, HFD+LPS or HFD+IL-1β did not induce a NASH-like phenotype and caused intrahepatic accumulation of almost exclusively mononuclear cells. By contrast, mice treated with metabolic triggers developed NASH, characterized by enhanced steatosis, hepatocellular hypertrophy, and formation of mixed-type inflammatory foci containing myeloperoxidase-positive granulocytes (neutrophils) as well as mononuclear cells, essentially as observed in human NASH. Specific for the metabolic inducers was an activation of the proinflammatory transcription factor activator protein-1 (AP-1), neutrophil infiltration, and induction of risk factors associated with human NASH, that is, dyslipidemia (by cholesterol) and insulin resistance (by carbohydrate). In conclusion, HFD feeding followed by NF-κB activation per se (LPS, IL-1β) does not promote the transition from BS to NASH. HFD feeding followed by metabolically evoked inflammation induces additional inflammatory components (neutrophils, AP-1 pathway) and causes NASH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24566933     DOI: 10.1038/labinvest.2014.11

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  31 in total

Review 1.  Types of dietary fat and risk of coronary heart disease: a critical review.

Authors:  F B Hu; J E Manson; W C Willett
Journal:  J Am Coll Nutr       Date:  2001-02       Impact factor: 3.169

2.  Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.

Authors:  Marit Westerterp; Caroline C van der Hoogt; Willeke de Haan; Erik H Offerman; Geesje M Dallinga-Thie; J Wouter Jukema; Louis M Havekes; Patrick C N Rensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-31       Impact factor: 8.311

Review 3.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

4.  Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.

Authors:  Rajat Singh; Yongjun Wang; Youqing Xiang; Kathryn E Tanaka; William A Gaarde; Mark J Czaja
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

5.  CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

Authors:  Silvia Bijland; Sjoerd A A van den Berg; Peter J Voshol; Anita M van den Hoek; Hans M G Princen; Louis M Havekes; Patrick C N Rensen; Ko Willems van Dijk
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 6.  The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.

Authors:  Kyoko Nomura; Toshikazu Yamanouchi
Journal:  J Nutr Biochem       Date:  2011-11-29       Impact factor: 6.048

7.  Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.

Authors:  Derrick M Van Rooyen; Lay T Gan; Matthew M Yeh; W Geoffrey Haigh; Claire Z Larter; George Ioannou; Narci C Teoh; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2013-03-07       Impact factor: 25.083

8.  Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression.

Authors:  Laurent Vergnes; Jack Phan; Merav Strauss; Sherrie Tafuri; Karen Reue
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

9.  Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.

Authors:  Jan H N Lindeman; Hazem Abdul-Hussien; J Hajo van Bockel; Ron Wolterbeek; Robert Kleemann
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690

10.  Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.

Authors:  Robert Kleemann; Marjan van Erk; Lars Verschuren; Anita M van den Hoek; Maud Koek; Peter Y Wielinga; Annie Jie; Linette Pellis; Ivana Bobeldijk-Pastorova; Thomas Kelder; Karin Toet; Suzan Wopereis; Nicole Cnubben; Chris Evelo; Ben van Ommen; Teake Kooistra
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more
  33 in total

Review 1.  Liver inflammation and fibrosis.

Authors:  Yukinori Koyama; David A Brenner
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.

Authors:  Melissa A Linden; Ryan D Sheldon; Grace M Meers; Laura C Ortinau; E Matthew Morris; Frank W Booth; Jill A Kanaley; Victoria J Vieira-Potter; James R Sowers; Jamal A Ibdah; John P Thyfault; M Harold Laughlin; R Scott Rector
Journal:  J Physiol       Date:  2016-05-27       Impact factor: 5.182

3.  Accelerated wound healing by injectable microporous gel scaffolds assembled from annealed building blocks.

Authors:  Donald R Griffin; Westbrook M Weaver; Philip O Scumpia; Dino Di Carlo; Tatiana Segura
Journal:  Nat Mater       Date:  2015-06-01       Impact factor: 43.841

4.  Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes.

Authors:  Wen Liang; Lars Verschuren; Petra Mulder; José W A van der Hoorn; Joanne Verheij; Andrea D van Dam; Mariette R Boon; Hans M G Princen; Louis M Havekes; Robert Kleemann; Anita M van den Hoek
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

Review 5.  Pathogenesis of nonalcoholic steatohepatitis.

Authors:  Wensheng Liu; Robert D Baker; Tavleen Bhatia; Lixin Zhu; Susan S Baker
Journal:  Cell Mol Life Sci       Date:  2016-02-19       Impact factor: 9.261

6.  Inflammatory Stimuli Trigger Increased Androgen Production and Shifts in Gene Expression in Theca-Interstitial Cells.

Authors:  Chelsea W Fox; Lingzhi Zhang; Abhishek Sohni; Manuel Doblado; Miles F Wilkinson; R Jeffrey Chang; Antoni J Duleba
Journal:  Endocrinology       Date:  2019-12-01       Impact factor: 4.736

7.  Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells.

Authors:  Akira Kado; Takeya Tsutsumi; Kenichiro Enooku; Hidetaka Fujinaga; Kazuhiko Ikeuchi; Kazuya Okushin; Kyoji Moriya; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2019-03-04       Impact factor: 7.527

Review 8.  The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).

Authors:  Marina Nati; David Haddad; Andreas L Birkenfeld; Christian A Koch; Triantafyllos Chavakis; Antonios Chatzigeorgiou
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

9.  Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study.

Authors:  Michelle T Long; Xiaoyu Zhang; Hanfei Xu; Ching-Ti Liu; Kathleen E Corey; Raymond T Chung; Rohit Loomba; Emelia J Benjamin
Journal:  Hepatology       Date:  2021-02-06       Impact factor: 17.298

10.  Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil.

Authors:  Martine C Morrison; Petra Mulder; P Mark Stavro; Manuel Suárez; Anna Arola-Arnal; Wim van Duyvenvoorde; Teake Kooistra; Peter Y Wielinga; Robert Kleemann
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.